(1)
Gomes, J. E. da C.; Santos, P. F. P. dos; Alvarenga, V. M. CARDIOVASCULAR BENEFITS OF CANAGLIFLOZIN USE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: AN INTEGRATIVE REVIEW. REASE 2025, 11 (10), 5153-5165. https://doi.org/10.51891/rease.v11i10.21802.